← Back to Patent Explorer
US4405608A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel peptide

Assignee: Novo Nordisk AS
•
Filing: 1981-08-27
•
Granted: 1983-09-20
•
Expires: 2001-08-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel, purified peptide having the following amino acid sequence: Arg-Ser-Leu-Gln-Asn-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Pro-Ala-Pro-Gln-Th r-Asp-Pro-Leu-Asp-Asp-Pro-Asp-Gln-Met-Thr-Glu-Asp. The peptide may be used as medicament, e.g., in the treatment of gastroduodenal ulcers.

Inventors

  • 👤 Alister J. Moody
  • 👤 Lars Thim
  • 👤 Karin D. Jorgensen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 10:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/605; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 16 words
A purified peptide having the following amino acid sequence: ##STR2## and the physiologically acceptable salts thereof.
Claim 2
Dependent Claim 16 words
A purified peptide having the following amino acid sequence: ##STR2## and the physiologically acceptable salts thereof.
Claim 3
Dependent Claim 30 words
A pharmaceutical composition for treatment of ulcer comprising an effective amount of the peptide having the following amino acid sequence: ##STR3## or a physiologically acceptable salt thereof in a carrier.
Claim 4
Dependent Claim 30 words
A pharmaceutical composition for treatment of ulcer comprising an effective amount of the peptide having the following amino acid sequence: ##STR3## or a physiologically acceptable salt thereof in a carrier.
Claim 5
Dependent Claim 24 words
The pharmaceutical composition of claim 2 further comprising an isotonic solution containing therein from 60 μg/ml to 30 mg/ml of said peptide or salt.
Claim 6
Dependent Claim 24 words
The pharmaceutical composition of claim 2 further comprising an isotonic solution containing therein from 0.6 mg/ml to 3 mg/ml of said peptide or salt.

References Cited (Backward Citations)

US81681A Cited
US2115418A Cited
US3803305A Cited
US3493399A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-09-19 1987-03-21 1987-09-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-09-19 1991-03-21 1991-09-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-09-19 1995-03-21 1995-09-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag